七家生物科技公司数据公布后瞄准23亿美元公开募股。
Seven biotechs eye $2.3B in public offerings after data readouts
生物技术与制药领域的最新动态
Seven biotechs eye $2.3B in public offerings after data readouts
ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data
NeurIPS 2025: Biology’s Transformer Moment - Genetic Engineering and Biotechnology News
Radial raises $50M to treat mental health in non-traditional ways
Male bonobo mating strategies target female fertile windows despite noisy ovulatory signals during sexual swelling
The luminal ring protein C2CD3 acts as a radial in-to-out organizer of the distal centriole and appendages
GSK goes away, Ideaya synthetic lethality bids in-house again
Accelerating Drug Discovery at Grove Biopharma with MyGlo® and ProNect®
Ossiam Sells 3,400 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Here Are Tuesday's Top Wall Street Analyst Research Calls: Agilent, Alibaba, Delta Air Lines, Intel, JD.com, Micron Technology, Reddit and More - 24/7 Wall St.
Agilent Technologies (A) Receives Buy Rating from Goldman Sachs | A Stock News - GuruFocus
Goldman Sachs Initiates Coverage on Thermo Fisher Scientific (TM - GuruFocus
How Lilly uses Big Pharma heft to lift up-and-coming biotechs
New antibody-drug conjugates disclosed in Genome & Co. patent
Merck Sharp & Dohme discovers new GTPase KRAS degradation inducers
#SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer
#ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped
J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma
Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
FDA steers cancer CAR-T developers toward randomized superiority trials in policy shift